Alimera Sciences organizacji Current ratio
Jaka jest wartość Current ratio organizacji Alimera Sciences?
Wartość Current ratio organizacji Alimera Sciences Inc. to 2.79
Jaka jest definicja Current ratio?
Wskaźnik bieżącej płynności to wskaźnik płynności, który określa, czy firma ma wystarczające zasoby, aby wywiązać się z zobowiązań krótkoterminowych.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio firm w Health Care sektor na NASDAQ w porównaniu do Alimera Sciences
Czym się zajmuję organizacja Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Firmy z current ratio podobne do Alimera Sciences
- Wartość Current ratio organizacji Eaton Vance Municipal Income Trust to 2.79
- Wartość Current ratio organizacji Corby Spirit & Wine to 2.79
- Wartość Current ratio organizacji ATENOR SA to 2.79
- Wartość Current ratio organizacji Atenor SA to 2.79
- Wartość Current ratio organizacji ON Semiconductor to 2.79
- Wartość Current ratio organizacji ChannelAdvisor Corp to 2.79
- Wartość Current ratio organizacji Alimera Sciences to 2.79
- Wartość Current ratio organizacji Akwel to 2.79
- Wartość Current ratio organizacji Akwel to 2.79
- Wartość Current ratio organizacji WiSA Technologies Inc to 2.79
- Wartość Current ratio organizacji Huffington Capital to 2.79
- Wartość Current ratio organizacji Monroe Capital Corp to 2.79
- Wartość Current ratio organizacji Chengdu Expressway Co to 2.79